A detailed history of Sivia Capital Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sivia Capital Partners, LLC holds 8,927 shares of NVO stock, worth $758,795. This represents 0.63% of its overall portfolio holdings.

Number of Shares
8,927
Previous 9,224 3.22%
Holding current value
$758,795
Previous $1.32 Billion 19.27%
% of portfolio
0.63%
Previous 0.88%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$119.07 - $145.42 $35,363 - $43,189
-297 Reduced 3.22%
8,927 $1.06 Billion
Q2 2024

Aug 05, 2024

BUY
$122.71 - $146.91 $95,100 - $113,855
775 Added 9.17%
9,224 $1.32 Billion
Q1 2024

Apr 18, 2024

SELL
$102.11 - $135.92 $5,513 - $7,339
-54 Reduced 0.64%
8,449 $1.08 Billion
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $746,393 - $896,641
8,503 New
8,503 $880 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sivia Capital Partners, LLC Portfolio

Follow Sivia Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivia Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivia Capital Partners, LLC with notifications on news.